Repression of the SUMO-conjugating enzyme UBC9 is associated with lowered double minutes and reduced tumor progression
- PMID: 38465861
- PMCID: PMC10936631
- DOI: 10.1080/15384047.2024.2323768
Repression of the SUMO-conjugating enzyme UBC9 is associated with lowered double minutes and reduced tumor progression
Abstract
Double minutes (DMs), extrachromosomal gene fragments found within certain tumors, have been noted to carry onco- and drug resistance genes contributing to tumor pathogenesis and progression. After screening for SUMO-related molecule expression within various tumor sample and cell line databases, we found that SUMO-conjugating enzyme UBC9 has been associated with genome instability and tumor cell DM counts, which was confirmed both in vitro and in vivo. Karyotyping determined DM counts post-UBC9 knockdown or SUMOylation inhibitor 2-D08, while RT-qPCR and Western blot were used to measure DM-carried gene expression in vitro. In vivo, fluorescence in situ hybridization (FISH) identified micronucleus (MN) expulsion. Western blot and immunofluorescence staining were then used to determine DNA damage extent, and a reporter plasmid system was constructed to detect changes in homologous recombination (HR) and non-homologous end joining (NHEJ) pathways. Our research has shown that UBC9 inhibition is able to attenuate DM formation and lower DM-carried gene expression, in turn reducing tumor growth and malignant phenotype, via MN efflux of DMs and lowering NHEJ activity to increase DNA damage. These findings thus reveal a relationship between heightened UBC9 activity, increased DM counts, and tumor progression, providing a potential approach for targeted therapies, via UBC9 inhibition.
Keywords: DNA damage repair; SUMOylation; UBC9; double minutes; genome instability.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Figures






Similar articles
-
UBC9-mediated SUMOylation of Lamin B1 enhances DNA-damage-induced nuclear DNA leakage and autophagy after spinal cord injury.J Cell Physiol. 2024 May;239(5):e31213. doi: 10.1002/jcp.31213. Epub 2024 Feb 3. J Cell Physiol. 2024. PMID: 38308641
-
Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation.J Biol Chem. 2017 Sep 15;292(37):15340-15351. doi: 10.1074/jbc.M117.794255. Epub 2017 Aug 7. J Biol Chem. 2017. PMID: 28784659 Free PMC article.
-
Nuclear accumulation of UBC9 contributes to SUMOylation of lamin A/C and nucleophagy in response to DNA damage.J Exp Clin Cancer Res. 2019 Feb 11;38(1):67. doi: 10.1186/s13046-019-1048-8. J Exp Clin Cancer Res. 2019. PMID: 30744690 Free PMC article.
-
SUMO Ubc9 enzyme as a viral target.IUBMB Life. 2014 Jan;66(1):27-33. doi: 10.1002/iub.1240. Epub 2014 Jan 6. IUBMB Life. 2014. PMID: 24395713 Review.
-
Enhanced detection of in vivo SUMO conjugation by Ubc9 fusion-dependent sumoylation (UFDS).Methods Mol Biol. 2009;497:63-79. doi: 10.1007/978-1-59745-566-4_5. Methods Mol Biol. 2009. PMID: 19107411 Review.
References
-
- Storlazzi CT, Lonoce A, Guastadisegni MC, Trombetta D, D’Addabbo P, Daniele G, L’Abbate A, Macchia G, Surace C, Kok K, et al. Gene amplification as double minutes or homogeneously staining regions in solid tumors: origin and structure. Genome Res. 2010; 20(9):1198–206. doi:10.1101/gr.106252.110. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous